The aim of BIOASTER is to bring together academic, industry and its capacities and specific knowledge to develop and execute high impact collaborative projects requiring industry compatible innovative technologies.

Key figures:
- 4 fields of expertise: antimicrobials, diagnostics, microbiota, vaccines
- BSL2 & BSL3 laboratories in Lyon and Paris
- 100+ employees, including 80% of scientific experts, 17 nationalities
- 330+ research contracts, involving 107 private partners, 54 public partners. 13 grants & European projects.